Tallac Therapeutics, Inc.
About Tallac Therapeutics, Inc.
Products & Services
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Debt T: - FT: Debt |
A: 15000000 MR: - FA: $15 million FAN: 15000000 |
D: 2023-08-02 FD: 2023-08-02 |
1 investors |
Growth Metrics
Team & Leadership
Hong I. Wan
President, Chief Executive Officer and Co-founder
Curtis C. Hecht
Chief Business Officer
Laura QM Chow
Interim Chief Medical Officer
Pavel Strop
Vice President, Research
Mark Karbarz
Executive Director, Biologics Development
Emma Abellana
Senior Director, Finance
Recent News
Tallac Therapeutics, Inc. Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- tallactherapeutics.com
- Industries
- Biopharmaceutical
- Company Size
- ~380 employees (est.)
Similar Companies
Discover AI-powered company recommendations based on industry, funding, and team profiles.
Upgrade to ProTechnology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro